Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ESAB | RDN |
|---|---|---|
| Price | $71.46 | $33.50 |
| Change today | ▲ 2.23% | ▲ 2.86% |
| Market cap | $4.44B | $4.43B |
| Return, 3 months | -23.9% | -11.3% |
| Return, year to date | -35.8% | -4.8% |
| Return, 1 year | -39.5% | -0.7% |
| P/E (TTM) | 26.0 | 8.6 |
| P/B | 1.9 | 0.9 |
| P/E percentile vs own 5y | 50th | – |
| Dividend yield | 0.59% | 3.04% |
| Revenue growth (YoY, latest qtr) | – | +92.6% |
| Net profit growth (YoY) | – | -18.3% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | 20.2% |
| Return on equity | – | – |
| Analyst target vs. price | +86.6% | +30.1% |
| Analyst buy share | 100% | 80% |
| RSI (14) | 51 | 45 |
| 30-day volatility | 45.3% | 30.9% |
| Max drawdown, 1 year | -51.7% | -22.4% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
